Chronic skin-specific inflammation promotes vascular inflammation and thrombosis

Journal of Investigative Dermatology

Volumn 132, Issue 8, 2012, Pages 2067-2075

  Wang, Yunmei ^a,b   Gao, Huiyun ^a,b   Loyd, Candace M ^a   Fu, Wen ^a   Diaconu, Doina ^a   Liu, Shijian ^a,b   Cooper, Kevin D ^a,b   McCormick, Thomas S ^a,b   Simon, Daniel I ^a,b   Ward, Nicole L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CD11B ANTIGEN; COLLAGEN; DOXYCYCLINE; ELASTIN; INTERLEUKIN 12; INTERLEUKIN 17; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; AORTITIS; ARTERY LESION; ARTERY THROMBOSIS; ARTICLE; B LYMPHOCYTE; BLOOD CLOTTING TIME; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION; SPLEEN CELL; T LYMPHOCYTE; THROMBOGENESIS; THROMBOSIS; VASCULITIS;

EID: 84863981183     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.112     Document Type: Article

References (58)

1. Ahlehoff O, Gislason GH, Jorgensen CH et al. (2011a) Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J; e-pub ahead of print 25 August 2011
2. Ahlehoff O, Gislason GH, Lindhardsen J et al. (2011b) Psoriasis carries an increased risk of venous thromboembolism: a Danish Nationwide Cohort Study. PLoS One 6:e18125
3. Alexandroff AB, Pauriah M, Camp RD et al. (2009) More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol 161:1-7
4. Balci DD, Balci A, Karazincir S et al. (2009) Increased carotid artery intimamedia thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol 23:1-6
5. Baldus S, Heeschen C, Meinertz T et al. (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108:1440-5
6. Bazzoni G, Dejana E, Del Maschio A (1991) Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 76:491-9
7. Benoit S, Toksoy A, Ahlmann M et al. (2006) Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. Br J Dermatol 155:62-6
8. Boehncke S, Fichtlscherer S, Salgo R et al. (2011a) Systemic therapy of plaque-type psoriasis ameliorates endothelial cell function: results of a prospective longitudinal pilot trial. Arch Dermatol Res 303:381-8
9. Boehncke S, Salgo R, Garbaraviciene J et al. (2011b) Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study. J Eur Acad Dermatol Venereol 25:1187-93
10. Boehncke WH, Boehncke S, Tobin AM et al. (2011c) The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 20:303-7
11. Croce K, Gao H, Wang Y et al. (2009) Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 120:427-36
12. Davies MJ, Thomas AC (1985) Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 53:363-73
13. DeStefano F, Anda RF, Kahn HS et al. (1993) Dental disease and risk of coronary heart disease and mortality. Br Med J 306:688-91
14. Diamond I, Owolabi T, Marco M et al. (2000) Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. J Invest Dermatol 115:788-94
15. Falati S, Gross PL, Merrill-Skoloff G et al. (2004) In vivo models of platelet function and thrombosis: study of real-time thrombus formation. Methods Mol Biol 272:187-97
16. Farb A, Burke AP, Tang AL et al. (1996) Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 93:1354-63
17. Federman DG, Shelling M, Prodanovich S et al. (2009) Psoriasis: an opportunity to identify cardiovascular risk. Br J Dermatol 160:1-7
18. Furie B, Furie BC (2005) Thrombus formation in vivo. J Clin Invest 115: 3355-62
19. Garbaraviciene J, Diehl S, Varwig D et al. (2010) Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis. Exp Dermatol 19:736-41
20. Gelfand JM, Dommasch ED, Shin DB et al. (2009) The risk of stroke in patients with psoriasis. J Invest Dermatol 129:2411-8
21. Gelfand JM, Neimann AL, Shin DB et al. (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735-41
22. Gisondi P, Fantin F, Del Giglio M et al. (2009) Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology 218:110-3
23. Gisondi P, Girolomoni G (2009) Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. Semin Thromb Hemost 35:313-24
24. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-95
25. Healy AM, Pickard MD, Pradhan AD et al. (2006) Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 113:2278-84
26. Humphrey LL, Fu R, Buckley DI et al. (2008) Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med 23:2079-86
27. Johnston A, Xing X, Guzman AM et al. (2011) IL-1F5,-F6,-F8, and-F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol 186:2613-22
28. Jones N, Voskas D, Master Z et al. (2001) Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO Rep 2:438-45
29. Kaur S, Zilmer K, Kairane C et al. (2008) Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis. Br J Dermatol 159:1364-7
30. Kryczek I, Bruce AT, Gudjonsson JE et al. (2008) Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 181:4733-41
31. Kuijper PH, Gallardo Torres HI, Lammers JW et al. (1997) Platelet and fibrin deposition at the damaged vessel wall: cooperative substrates for neutrophil adhesion under flow conditions. Blood 89:166-75
32. Li N, Hu H, Lindqvist M et al. (2000) Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 20:2702-8
33. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868-74
34. Libby P, Simon DI (2001) Inflammation and thrombosis: the clot thickens. Circulation 103:1718-20
35. Lindemann S, Tolley ND, Dixon DA et al. (2001) Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 154:485-90
36. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866-73
37. Ludwig RJ, Herzog C, Rostock A et al. (2007) Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 156:271-6
38. Mehta NN, Azfar RS, Shin DB et al. (2010) Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 31:1000-6
39. Mehta NN, Yu Y, Pinnelas R et al. (2011a) Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 124:775
40. (e1-6) Mehta NN, Yu Y, Saboury B et al. (2011b) Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Arch Dermatol 2011:1031-9
41. Morrow DA, Wang Y, Croce K et al. (2008) Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE ITTIMI 22) trial. Am Heart J 155:49-55
42. Nagata K, Tsuji T, Todoroki N et al. (1993) Activated platelets induce superoxide anion release by monocytes and neutrophils through Pselectin (CD62). J Immunol 151:3267-73
43. Ostrowski SM, Belkadi A, Loyd CM et al. (2011) Cutaneous denervation of psoriasiform mouse skin improves acanthosis and inflammation in a sensory neuropeptide-dependent manner. J Invest Dermatol 131:1530-8
44. Papapanou PN, Sedaghatfar MH, Demmer RT et al. (2007) Periodontal therapy alters gene expression of peripheral blood monocytes. J Clin Periodontol 34:736-47
45. Pietrzak A, Kadzielewski J, Janowski K et al. (2009) Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity. Int J Dermatol 48:379-87
46. Prodanovich S, Kirsner RS, Kravetz JD et al. (2009) Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 145:700-3
47. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-26
48. Shepherd J, Little MC, Nicklin MJ (2004) Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. J Invest Dermatol 122:665-9
49. Shi C, Sakuma M, Mooroka T et al. (2008) Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood 112:4699-711
50. Silver R, Helms A, Fu Wet al. (2011) Using optical coherence tomography for the longitudinal noninvasive evaluation of epidermal thickness in a murine model of chronic skin inflammation. Skin Res Technol; e-pub ahead of print 14 September 2011
51. Spah F (2008) Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol 159:10-7
52. Swindell WR, Johnston A, Carbajal S et al. (2011) Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One 6:e18266
53. Swirski FK, Libby P, Aikawa E et al. (2007) Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 117:195-205
54. Takahashi H, Tsuji H, Takahashi I et al. (2008) Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol 159:1207-8
55. Toker A, Kadi M, Yildirim AK et al. (2009) Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct 27:176-80
56. Ward NL, Loyd CM, Wolfram JA et al. (2011) Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice. Br J Dermatol 164:750-8
57. Watson BD, Dietrich WD, Busto R et al. (1985) Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol 17:497-504
58. Wolfram JA, Diaconu D, Hatala DA et al. (2009) Keratinocyte but not endothelial cell specific overexpression of Tie2 leads to the development of psoriasis. Am J Pathol 174:1443-58